E
EuBiologics Co Ltd
KOSDAQ:206650
EuBiologics Co Ltd
KOSDAQ:206650
Price:
13 460
KRW
-1.82%
Market Closed
Market Cap:
₩493.6B
Balance Sheet
Balance Sheet Decomposition
EuBiologics Co Ltd
EuBiologics Co Ltd
Balance Sheet Decomposition is not available for
EuBiologics Co Ltd
EuBiologics Co Ltd
Balance Sheet
EuBiologics Co Ltd
EuBiologics Co Ltd
Currency: KRW
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Cash & Cash Equivalents |
624
|
2 226
|
292
|
1 061
|
9 641
|
11 355
|
5 667
|
53 088
|
6 535
|
11 044
|
9 897
|
22 854
|
|
| Cash |
624
|
612
|
292
|
1 059
|
8 260
|
9 121
|
3 586
|
53 027
|
5 729
|
0
|
5 130
|
6 411
|
|
| Cash Equivalents |
0
|
1 614
|
0
|
2
|
1 381
|
2 234
|
2 081
|
61
|
806
|
11 044
|
4 767
|
16 443
|
|
| Short-Term Investments |
0
|
0
|
2 106
|
2
|
0
|
8 000
|
4 066
|
0
|
25 010
|
0
|
0
|
0
|
|
| Total Receivables |
153
|
188
|
137
|
335
|
436
|
3 296
|
2 787
|
6 383
|
3 917
|
5 547
|
12 099
|
12 076
|
|
| Accounts Receivables |
0
|
0
|
0
|
333
|
413
|
1 325
|
2 202
|
4 764
|
3 544
|
5 180
|
9 401
|
9 220
|
|
| Other Receivables |
153
|
0
|
0
|
2
|
23
|
1 971
|
585
|
1 619
|
373
|
367
|
2 698
|
2 856
|
|
| Inventory |
0
|
1 602
|
3 946
|
4 785
|
4 554
|
4 541
|
7 669
|
9 252
|
14 776
|
18 013
|
13 342
|
30 402
|
|
| Other Current Assets |
20
|
602
|
33
|
296
|
609
|
452
|
1 308
|
2 683
|
3 482
|
6 535
|
6 426
|
17 810
|
|
| Total Current Assets |
797
|
4 617
|
6 514
|
6 479
|
15 240
|
27 645
|
21 497
|
71 407
|
53 720
|
41 139
|
41 764
|
83 143
|
|
| PP&E Net |
3 274
|
4 439
|
6 498
|
5 942
|
10 307
|
35 033
|
64 679
|
68 538
|
70 046
|
72 815
|
70 096
|
76 100
|
|
| PP&E Gross |
3 274
|
4 439
|
6 498
|
5 942
|
10 307
|
35 033
|
64 679
|
68 538
|
70 046
|
72 815
|
70 096
|
76 100
|
|
| Accumulated Depreciation |
532
|
1 461
|
2 722
|
4 402
|
6 468
|
14 147
|
12 035
|
17 992
|
24 716
|
33 338
|
42 811
|
50 223
|
|
| Intangible Assets |
1 982
|
65
|
70
|
53
|
230
|
454
|
1 138
|
3 032
|
4 884
|
23 336
|
16 682
|
18 348
|
|
| Goodwill |
0
|
889
|
889
|
889
|
889
|
889
|
889
|
889
|
889
|
889
|
889
|
889
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
405
|
621
|
1 649
|
353
|
782
|
202
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
270
|
248
|
8 632
|
11 806
|
16 041
|
15 410
|
15 042
|
|
| Other Long-Term Assets |
93
|
127
|
170
|
127
|
186
|
3 947
|
3 909
|
2 836
|
7 444
|
7 492
|
6 182
|
8 361
|
|
| Other Assets |
0
|
889
|
889
|
889
|
889
|
889
|
889
|
889
|
889
|
889
|
889
|
889
|
|
| Total Assets |
6 146
N/A
|
10 137
+65%
|
14 141
+39%
|
13 489
-5%
|
26 852
+99%
|
68 238
+154%
|
92 765
+36%
|
155 955
+68%
|
150 438
-4%
|
162 066
+8%
|
151 806
-6%
|
202 085
+33%
|
|
| Liabilities | |||||||||||||
| Accounts Payable |
413
|
541
|
8
|
189
|
231
|
156
|
296
|
199
|
308
|
856
|
636
|
11 436
|
|
| Accrued Liabilities |
0
|
68
|
187
|
84
|
162
|
134
|
1 398
|
2 038
|
0
|
3 333
|
677
|
1 654
|
|
| Short-Term Debt |
205
|
50
|
50
|
1 100
|
0
|
0
|
0
|
4 500
|
2 500
|
8 500
|
8 656
|
8 500
|
|
| Current Portion of Long-Term Debt |
145
|
50
|
3 968
|
0
|
842
|
14 917
|
10 227
|
698
|
8 219
|
1 433
|
1 777
|
879
|
|
| Other Current Liabilities |
1 010
|
1 226
|
7 997
|
3 433
|
4 417
|
8 544
|
15 571
|
27 762
|
6 255
|
10 502
|
13 953
|
20 576
|
|
| Total Current Liabilities |
1 773
|
1 935
|
12 211
|
4 807
|
5 652
|
23 751
|
27 491
|
35 197
|
17 282
|
24 624
|
25 699
|
43 044
|
|
| Long-Term Debt |
50
|
9 085
|
6 113
|
3 467
|
2 416
|
18 461
|
27 122
|
17 373
|
6 219
|
5 729
|
4 346
|
3 572
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2 736
|
5 075
|
6 555
|
0
|
|
| Other Liabilities |
238
|
15 342
|
7 438
|
1 823
|
633
|
481
|
3 200
|
6 509
|
9 673
|
12 277
|
16 943
|
23 436
|
|
| Total Liabilities |
2 061
N/A
|
26 363
+1 179%
|
25 762
-2%
|
10 096
-61%
|
8 700
-14%
|
42 693
+391%
|
57 813
+35%
|
59 079
+2%
|
30 439
-48%
|
37 556
+23%
|
40 433
+8%
|
70 052
+73%
|
|
| Equity | |||||||||||||
| Common Stock |
6 277
|
3 945
|
5 074
|
10 468
|
12 225
|
12 783
|
13 396
|
17 433
|
18 137
|
18 222
|
18 227
|
18 267
|
|
| Retained Earnings |
5 639
|
20 828
|
23 837
|
30 512
|
35 227
|
31 447
|
32 416
|
92 551
|
120 125
|
121 224
|
135 103
|
115 986
|
|
| Additional Paid In Capital |
3 447
|
539
|
6 805
|
23 031
|
40 625
|
44 002
|
53 566
|
171 522
|
219 542
|
220 859
|
223 103
|
224 061
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
280
|
539
|
621
|
1 377
|
|
| Other Equity |
0
|
118
|
337
|
406
|
529
|
206
|
406
|
472
|
2 165
|
6 113
|
4 525
|
4 313
|
|
| Total Equity |
4 085
N/A
|
16 226
N/A
|
11 621
+28%
|
3 393
N/A
|
18 152
+435%
|
25 544
+41%
|
34 952
+37%
|
96 877
+177%
|
119 999
+24%
|
124 510
+4%
|
111 373
-11%
|
132 033
+19%
|
|
| Total Liabilities & Equity |
6 146
N/A
|
10 137
+65%
|
14 141
+39%
|
13 489
-5%
|
26 852
+99%
|
68 238
+154%
|
92 765
+36%
|
155 955
+68%
|
150 438
-4%
|
162 066
+8%
|
151 806
-6%
|
202 085
+33%
|
|
| Shares Outstanding | |||||||||||||
| Common Shares Outstanding |
8
|
8
|
10
|
21
|
25
|
26
|
27
|
36
|
36
|
36
|
36
|
37
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
